Share

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Prevention and Early Detection Resources:

Our ability to continue to make progress against cancer relies heavily on eliminating inequities that exist in breast cancer prevention and treatment. That is why ACS CAN advocates for policies to reduce the disparities in breast cancer by improving access to prevention and early detection services, patient navigation services, insurance coverage, in-network facilities, and clinical trials.

Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.

Current federal law provides life-saving coverage of cancer prevention and early detection services and programs.  These provisions are crucial to reducing the incidence and impact of cancer in the United States.  They are also crucial in helping cancer survivors remain cancer-free and lead healthy lives.

  •  

Screening Resources:

After declining through much of the late 2000s and early 2010s, prostate cancer incidence rates have risen for nearly a decade. The increase includes distant-stage disease diagnoses among men of all ages, climbing by nearly 3% annually among those younger than 55 years.

The American Cancer Society Cancer Action Network (ACS CAN) calls on Congress to support the Centers for Disease Control and Prevention’s (CDC) NationalProgram for Cancer Registries (NPCR). Accessible, high-quality and usable registry data is critical to protect health and save lives.

The CDC’s Division of Cancer Prevention and Control (DCPC) plays a crucial role in providing millions of screening exams, funding state cancer registries, providing technical assistance and funding to state cancer control programs and educating the public directly on how to reduce their risk of c

The Centers for Disease Control and Prevention’s (CDC) Colorectal Cancer Control Program (CRCCP) provides grant funding to 20 state health departments, eight universities, two tribal organizations, and five other organizations to help prevent colorectal cancer, the third most common cancer in men and women and the second leading cause of cancer death in the U.S. for men and women combined.

El cáncer de seno es el tipo de cáncer que se diagnostica con mayor frecuencia en mujeres en EE.UU. Aunque en lasúltimas décadas se han logrado avances sustanciales en la reducción de la mortalidad por esta enfermedad,persisten desigualdades, especialmente entre las mujeres de raza negra.

The American Cancer Society Cancer Action Network (ACS CAN) urges Congress to reauthorize the the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to provide the program greater flexibility to NBCCEDP grantees, enabling them to implement evidence-based lifesaving screening, diagnostic, and treatment services and continue the innovative work aimed to reduce breast and cervical cancer disparities by passing the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) forCancer Act (H.R. 2381/S. 1866). This is critical to overall efforts to ensure that everyone has a fair and just opportunity toprevent, detect, treat and survive cancer.

Breast cancer screening is a continuum. It begins with a screening mammogram, which is often free for most insured women.

ACS CAN supports the Access to Breast Cancer Diagnosis Act to increase access to no cost breast cancer screening, including all diagnostic and supplemental tests.

Our latest survey finds that 31% of screening-age adults have been more than one year behind on recommended routine cancer screenings. Over half say out-of-pocket costs are a barrier to getting screened, while 47% report that getting insurance approvals for covered screenings is a barrier.